This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Turmeric
- DrugBank Accession Number
- DB14276
- Background
Turmeric is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
- Type
- Biotech
- Groups
- Approved, Experimental, Investigational
- Synonyms
- Ae-turmeric
- Allergenic Extract- Turmeric Curcuma Longa
- Amomum Curcuma Root
- Constrained Metal (Curcuma Longa)
- Curcuma Brog Root
- Curcuma Domestica Extract
- Curcuma Domestica Root
- Curcuma Euchroma Root
- Curcuma Longa
- Curcuma Longa (Turmeric) Rhizome Extract
- Curcuma Longa (Turmeric) Root
- Curcuma Longa (Turmeric) Root Extract
- Curcuma Longa (Turmeric) Root Powder
- Curcuma Longa Extract
- Curcuma Longa Rhizome
- Curcuma Longa Rhizome Extract
- Curcuma Longa Root
- Curcuma Longa Root Dry Extract
- Curcuma Longa Root Extract
- Curcuma Longa Root Tuber
- Curcuma Montana Root
- Curcuma Ochrorhiza Root
- Curcuma Soloensis Root
- Curcuma Viridiflora Root
- Curcumae Longae Rhizoma
- Curcumae Longae Rhizoma (Cucuma Longa)
- Curcumae Longae Rhizoma (Curcuma Longa)
- Curcumae Radix (Curcuma Longa)
- Curcumae Rhizoma (Curcuma Longa)
- Curcumarum Tuber Et Radix (Curcuma Longa)
- Ginger Yellow (Curcuma Longa)
- Guiyujin (Curcuma Longa)
- Haldi Root
- Haridra Root
- Huangsiyujin (Cucuma Longa)
- Indian Saffron Root
- Jiang Huang (Curcuma Longa)
- Jianghuang
- Kua Domestica Root
- Lusiyujin (Curcuma Longa)
- Spices, Turmeric, Ground
- Stissera Curcuma Root
- Stissera Longa Root
- Turmeric Extract
- Turmeric Rhizome (Curcuma Longa)
- Turmeric Root
- Turmeric Root Extract
- Turmeric Root Powder
- Turmeric Root Tuber (Curcuma Longa)
- Turmeric Tuber (Curcuma Longa)
- Turmeric,ground
- Wunyujin (Cucuma Longa)
- Yellow Ginger Root
- Yu Jin
- Yujin (Curcuma Longa)
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Used in combination for symptomatic treatment of Osteoarthritis (oa) Combination Product in combination with: Chondroitin sulfate (DB09301), Glucosamine (DB01296), Ascorbic acid (DB00126), Manganese (DB06757) •••••••••••• ••••• ••••••• •••• •••••• - Associated Therapies
- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- No interactions found.
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Milk Thistle Plus Turmeric Turmeric (150 mg / cap) + Milk thistle (5.6 g / cap) Capsule Oral Puresource Inc. Not applicable Not applicable Canada 
OSTEOFLEX FILM TABLET, 30 ADET Turmeric (100 mg) + Ascorbic acid (100 mg) + Chondroitin sulfate (400 mg) + Glucosamine sulfate (500 mg) + Manganese (2 mg) Tablet, film coated Oral MEDCONCEPT ILAC SAN. VE TIC. A.S. 2020-08-14 Not applicable Turkey 
OSTEOFLEX FILM TABLET, 90 ADET Turmeric (100 mg) + Ascorbic acid (100 mg) + Chondroitin sulfate (400 mg) + Glucosamine sulfate (500 mg) + Manganese (2 mg) Tablet, film coated Oral MEDCONCEPT ILAC SAN. VE TIC. A.S. 2017-05-16 Not applicable Turkey Tru-micin Turmeric (0.01 g/100mL) + Ginger (0.01 g/100mL) + Indian frankincense (0.01 g/100mL) + Lipoic acid (0.01 g/100mL) + Ocimum tenuiflorum top (0.01 g/100mL) + Rosemary (0.01 g/100mL) + Salix alba bark (0.01 g/100mL) Lotion Topical Truceuticals, Llc 2011-05-25 2013-08-14 US 
Tru-micin Turmeric (0.01 g/100mL) + Ginger (0.01 g/100mL) + Indian frankincense (0.01 g/100mL) + Lipoic acid (0.01 g/100mL) + Ocimum tenuiflorum top (0.01 g/100mL) + Rosemary (0.01 g/100mL) + Salix alba bark (0.01 g/100mL) Lotion Topical Dispensing Solutions, Inc. 2011-05-25 2013-08-14 US - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Tru-micin Turmeric (0.01 g/100mL) + Ginger (0.01 g/100mL) + Indian frankincense (0.01 g/100mL) + Lipoic acid (0.01 g/100mL) + Ocimum tenuiflorum top (0.01 g/100mL) + Rosemary (0.01 g/100mL) + Salix alba bark (0.01 g/100mL) Lotion Topical Truceuticals, Llc 2011-05-25 2013-08-14 US Tru-micin Turmeric (0.01 g/100mL) + Ginger (0.01 g/100mL) + Indian frankincense (0.01 g/100mL) + Lipoic acid (0.01 g/100mL) + Ocimum tenuiflorum top (0.01 g/100mL) + Rosemary (0.01 g/100mL) + Salix alba bark (0.01 g/100mL) Lotion Topical Dispensing Solutions, Inc. 2011-05-25 2013-08-14 US
Categories
- Drug Categories
- Angiosperms
- Antioxidants
- Biological Factors
- Biological Products
- Complex Mixtures
- Compounds used in a research, industrial, or household setting
- Condiments
- Embryophyta
- Eukaryota
- Lilianae
- Pharmaceutical Preparations
- Plant Extracts
- Plant Preparations
- Protective Agents
- Streptophyta
- Tracheophyta
- Viridiplantae
- Zingiberaceae
- Zingiberales
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 856YO1Z64F
- CAS number
- Not Available
References
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count 4 Completed Treatment Chronic Periodontitis (Disorder) 1 4 Not Yet Recruiting Treatment Horizontal Alveolar Bone Loss 1 3 Completed Treatment Platelet Function Tests 1 3 Completed Treatment Proteinuria 1 2 Active Not Recruiting Prevention Chronic Atrophic Gastritis (CAG) 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Tablet Oral Tablet, film coated Oral Lotion Topical Capsule Oral Capsule 250 mg - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at July 05, 2018 17:13 / Updated at June 22, 2021 18:16